Hope for teens with Never-Ending headaches: new drug shows promise
NCT ID NCT06018025
First seen Jan 11, 2026 · Last updated Jun 08, 2026 · Updated 20 times
Summary
This study looked at children and teens aged 10-18 who have a constant headache every day (called New Daily Persistent Headache). Researchers gave them a monthly injection of a medicine that blocks a protein linked to headaches (CGRP) and checked if their headaches got better. They also measured certain substances in the blood before and after treatment to see if they could predict who would respond best.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEW PERSISTENT DAILY HEADACHE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Health System
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.